Skip to main content

Table 1 Distribution of novel drug approvals by designation and indication.

From: Establishing a reasonable price for an orphan drug

  Non-oncology Oncology Total
Orphan drugs 36 35 71
Non-orphan drugs 58 53 111
Total 94 88 182
\